Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Founded in 1994 (incorporated in 1998), GenBio is a private, revenue-generating diagnostics company headquartered in Salt Lake City, Utah. It has established itself as a commercial-stage player with a broad portfolio of immunoassay kits for infectious and autoimmune diseases, distributed worldwide through a specialized network. The company's strategy emphasizes rapid commercialization, custom product development for specific markets, and maintaining rigorous regulatory compliance to serve global laboratory needs.

Infectious DiseaseAutoimmune Disease

Technology Platform

Immunoassay (primarily ELISA) development and manufacturing platform for serological detection of antibodies, leveraging licensed IP from governments and academic institutions.

Opportunities

The growing global demand for reliable and cost-effective infectious disease testing, coupled with increased recognition of autoimmune disorders, provides a stable market foundation.
Opportunities exist in developing custom assays for emerging pathogens or regional health priorities, and in leveraging its regulatory expertise to enter new geographic markets through its distributor network.

Risk Factors

Key risks include technological obsolescence as newer diagnostic platforms gain market share, sustained pricing pressure from healthcare systems, and intense competition from larger, capital-rich IVD corporations.
Dependency on distributor partners and potential regulatory changes also pose significant operational risks.

Competitive Landscape

GenBio competes in the crowded serology diagnostics market against global IVD leaders (e.g., Abbott, Roche, DiaSorin) who offer automated, high-throughput systems, as well as against numerous smaller specialty manufacturers. Its competitive edge lies in its focus on immunoassay expertise, flexibility for custom products, and a value-oriented proposition for laboratories using manual or semi-automated ELISA workflows.